Ann: ViewnVivo installed for evaluation at Stanford University, page-3

Positive news no doubt, better news than the sales in china imo (and that was very good news). management better at making the right contacts, better at networking than the last lot who were at it for so long. (or maybe oil's time has come, partly thanks to previous legwork).

a couple of idle ponderings:

Not giving investment advice but selling now would be interesting timing. the fda clearance for the zeiss product can't be too far away. it is not a drug and the approval process is being run by zeiss; is there any genuine doubt the approval will come? must be a 99% chance to be approved.

Does anyone doubt there will be an increase in price once approval is granted?